TerminatedNCT00391001

Taurine in Adolescents With Bipolarity

Medication studyAges 13–18United States

The study in practice

Understand this study

This study is for people with bipolarity. Listed age limits: 13 years to 18 years. Other eligibility criteria apply.

Listed locations: Belmont and 1 more locationSee all locations and recruitment
Study phase: Phase 1

A point to clarify

This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?

Study clarity

Study start dateFebruary 2006

Recruitment status: Terminated
Enrollment listed in the registry: 4
Sponsor: Cambridge Health Alliance
Sponsor type: Unknown or unclear
Study type: Drug
Intervention type: Drug
Study phase: Phase 1
Locations: United States
Age range: From 13 Years to 18 Years
Official registry ID: NCT00391001
Official title: Show the full official title
Taurine as an Anti-Manic Agent: A Double-Blind, Placebo-Controlled Study in Adolescents With Bipolar Disorder

Terminated

Belmont · Medford

FAQ

Who is behind this study?

The study sponsor is Cambridge Health Alliance.

Does this study involve medication?

Yes. The study involves medication, including Taurine.

Who can participate?

This study is for people with bipolarity. Listed age limits: 13 years to 18 years. Other eligibility criteria apply.

Is this study still recruiting?

The registry lists this study as terminated.